A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Clinical trial NCT06456580 · RECRUITING

Trial details

NCT number: NCT06456580
Sponsor: Vor Biopharma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Myasthenia Gravis

Start date: 2024-07-17
Primary completion: 2027-05-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.